Source:http://linkedlifedata.com/resource/umls/id/C1720829
MSH: Use of doses at only 1% of the pharmacological dose in humans in order to evaluate the pharmacokinetics. Such trials are sometimes referred to as phase zero trials.
Download in:
View as
